O-09: DURABLE ENGRAFTMENT AFTER PHARMACOLOGICAL PRE-TRANSPLANT IMMUNOSUPPRESSION FOLLOWED BY REDUCED-TOXICITY MYELOABLATIVE HAPLOIDENTICAL STEM CELL TRANSPLANTATION IN HIGHLY HLA-I... by FÜRST S., BERNIT E., GRANATA A., LEGRAND F., HARBI S., DEVILLIER R., MAISANO V., BOUCHACOURT B., PAGLIARDINI T., MOKART D., LEMARIÉ C., CALMELS B., PICARD C., BASIRE A., CHABANNON C., ANDERSSON B., BLAISE D.

Get full text

Characterization of factors determining the kinetics of disease relapse after allogeneic Stem Cell Transplantation (allo-SCT) or chemotherapeutic consolidation for Acute Myeloid Le... by Craddock, C, Versluis, J, Labopin, M, Socie, G, Huyn, A, Deconinck, E, Volin, L, Milpied, N, Bourhis, JH, Rambaldi, A, Chevallier, P, Blaise, D, Markus, M, Vellenga, E, Vekemans, MC, Maertens, J, Passweg, JR, Schmid, C, Ossenkoppele, GJ, Vyas, P, Löwenberg, B, Mohty, M, Cornelissen, JJ, Nagler, A

Distinct factors determine the kinetics of disease relapse in adults transplanted for acute myeloid leukaemia by Craddock, C, Versluis, J, Labopin, M, Socie, G, Huynh, A, Deconinck, E, Volin, L, Milpied, N, Bourhis, JH, Rambaldi, A, Chevallier, P, Blaise, D, Manz, M, Vellenga, E, Vekemans, MC, Maertens, J, Passweg, J, Vyas, P, Schmid, C, Löwenberg, B, Ossenkoppele, G, Mohty, M, Cornelissen, JJ, Nagler, A, Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation and HOVON‐SAKK